Safety and efficacy of pemigatinib plus pembrolizumab combination therapy in patients (pts) with advanced malignancies: Results from FIGHT-101, an open-label phase I/II study. Meeting Abstract (Web of Science)

Industry Collaboration International Collaboration

cited authors

  • Gutierrez, Martin; Subbiah, Vivek; Nemunaitis, John J.; Mettu, Niharika B.; Papadopoulos, Kyriakos P.; Barve, Minal A.; Feliz, Luis; Lihou, Christine Francis; Tian, Chenwei; Ji, Tao; Silverman, Ian M.; Chugh, Rashmi; Saleh, Mansoor N.

publication date

  • May 20, 2020

webpage

published in

category

volume

  • 38

issue

  • 15